http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2299051-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0de3c2a3b6a654048399cc756869a0f3 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
filingDate | 2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2007-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65835f8779f2b59f6aaa14e531337527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eee976623e41cddebab640c5b79260d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb27c74b52f1b367777b6d963e14656a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7dcfc38489eba6d4ead6a954bbe6943f |
publicationDate | 2007-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2299051-C1 |
titleOfInvention | Method for intraoperationally stopping epiretinal hemorrhages and removing epiretinal blood |
abstract | FIELD: medicine. n SUBSTANCE: method involves introducing hemostatic sponge via sclerostoma into vitreous cavity filled with polyorganophosphoroous compound. Sponge is 1.5 x 2 mm large. The sponge is pressed to epiretinal hemorrhage place on the retina for a time needed to achieve complete hemostasis. Then, epiretinal hemorrhage places are dried above the retina. n EFFECT: enhanced effectiveness in removing blood without polyorganophosphoroous compound loss taking place; accelerated operation; reduced risk of secondary hemorrhages and neovascular proliferative membrane recurrence. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2611920-C1 |
priorityDate | 2005-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Predicate | Subject |
---|---|
isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526573 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID74483 |
Total number of triples: 17.